ZERO PROSTATE CANCER

Lobbying for ZERO PROSTATE CANCER · Prostate Cancer Non-Profit, Health and Wellness

Filing 4th Quarter - Report

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 20, 2026

Expenses

$130,000.00

What this organization spent lobbying with its own staff. Reported using A: the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

Virginia

Official filing document

Government bodies contacted 2

HOUSE OF REPRESENTATIVES
SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Bills named in this filing 1

HR 1300
PSA Screening for HIM Act

Lobbying activity 4

Budget/Appropriations

FY2026 Appropriations. Defense - Prostate Cancer Research Program; L-HHS - Prostate Cancer Activities, Division of Cancer Prevention and Control at the CDC, National Cancer Institute, National Institutes of Health

Health Issues

HR 1300/S 293 PSA Screening for HIM Act - eliminating cost sharing for prostate cancer screening Extension of enhanced Advance Premium Tax Credits for Marketplace plans

Insurance

HR 1300/S 293 PSA Screening for HIM Act - eliminating cost sharing for prostate cancer screening, extension of enhanced Advance Premium Tax Credits for Marketplace plans

Veterans

VA Precision Oncology Program for Cancer of the Prostate

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.